Abstract
The effective drug design, especially for combating the multi-drug-resistant bacterial pathogens, requires more and more sophisticated procedures to obtain novel lead-like compounds. New classes of enzymes should be explored, especially those that help bacteria overcome existing treatments. The homology modeling is useful in obtaining the models of new enzymes; however, the active sites of them are sometimes present in closed conformations in the crystal structures, not suitable for drug design purposes. In such difficult cases, the combination of homology modeling, molecular dynamics simulations, and fragment screening can give satisfactory results.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Franca TC (2015) Homology modeling: an important tool for the drug discovery. J Biomol Struct Dyn 33:1780–1793. https://doi.org/10.1080/07391102.2014.971429
Muhammed MT, Aki-Yalcin E (2019) Homology modeling in drug discovery: overview, current applications, and future perspectives. Chem Biol Drug Des 93:12–20. https://doi.org/10.1111/cbdd.13388
Haddad Y, Adam V, Heger Z (2020) Ten quick tips for homology modeling of high-resolution protein 3D structures. PLoS Comput Biol 16:e1007449. https://doi.org/10.1371/journal.pcbi.1007449
Webb B, Sali A (2017) Protein structure modeling with MODELLER. Methods Mol Biol 1654:39–54. https://doi.org/10.1007/978-1-4939-7231-9_4
Waterhouse A, Bertoni M, Bienert S et al (2018) SWISS-MODEL: homology modelling of protein structures and complexes. Nucleic Acids Res 46:W296–W303. https://doi.org/10.1093/nar/gky427
Kelm S, Shi J, Deane CM (2010) MEDELLER: homology-based coordinate generation for membrane proteins. Bioinformatics 26:2833–2840. https://doi.org/10.1093/bioinformatics/btq554
Haas J, Barbato A, Behringer D et al (2018) Continuous Automated Model EvaluatiOn (CAMEO) complementing the critical assessment of structure prediction in CASP12. Proteins 86(Suppl 1):387–398. https://doi.org/10.1002/prot.25431
Robin X, Haas J, Gumienny R et al (2021) Continuous Automated Model EvaluatiOn (CAMEO)-Perspectives on the future of fully automated evaluation of structure prediction methods. Proteins 89:1977–1986. https://doi.org/10.1002/prot.26213
Laskowski RA, MacArthur MW, Moss DS et al (1993) PROCHECK: a program to check the stereochemical quality of protein structures. J Appl Crystallogr 26:283–291. https://doi.org/10.1107/S0021889892009944
Hooft RW, Vriend G, Sander C et al (1996) Errors in protein structures. Nature 381:272. https://doi.org/10.1038/381272a0
Sippl MJ (1993) Recognition of errors in three-dimensional structures of proteins. Proteins 17:355–362. https://doi.org/10.1002/prot.340170404
Chen VB, Arendall WB 3rd, Headd JJ et al (2010) MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr D Biol Crystallogr 66:12–21. https://doi.org/10.1107/S0907444909042073
Mysinger MM, Carchia M, Irwin JJ et al (2012) Directory of useful decoys, enhanced (DUD-E): better ligands and decoys for better benchmarking. J Med Chem 55:6582–6594. https://doi.org/10.1021/jm300687e
Latti S, Niinivehmas S, Pentikainen OT (2016) Rocker: open source, easy-to-use tool for AUC and enrichment calculations and ROC visualization. J Cheminform 8:45. https://doi.org/10.1186/s13321-016-0158-y
Spyrakis F, Benedetti P, Decherchi S et al (2015) A pipeline to enhance ligand virtual screening: integrating molecular dynamics and fingerprints for ligand and proteins. J Chem Inf Model 55:2256–2274. https://doi.org/10.1021/acs.jcim.5b00169
Pinzi L, Rastelli G (2019) Molecular docking: shifting paradigms in drug discovery. Int J Mol Sci 20:4331. https://doi.org/10.3390/ijms20184331
Brott AS, Clarke AJ (2019) Peptidoglycan O-acetylation as a virulence factor: its effect on lysozyme in the innate immune system. Antibiotics (Basel) 8:94. https://doi.org/10.3390/antibiotics8030094
Sychantha D, Jones CS, Little DJ et al (2017) In vitro characterization of the antivirulence target of Gram-positive pathogens, peptidoglycan O-acetyltransferase A (OatA). PLoS Pathog 13:e1006667. https://doi.org/10.1371/journal.ppat.1006667
Blum M, Chang HY, Chuguransky S et al (2021) The InterPro protein families and domains database: 20 years on. Nucleic Acids Res 49:D344–D354. https://doi.org/10.1093/nar/gkaa977
Letunic I, Bork P (2021) Interactive Tree Of Life (iTOL) v5: an online tool for phylogenetic tree display and annotation. Nucleic Acids Res 49:W293–W296. https://doi.org/10.1093/nar/gkab301
Sterling T, Irwin JJ (2015) ZINC 15--ligand discovery for everyone. J Chem Inf Model 55:2324–2337. https://doi.org/10.1021/acs.jcim.5b00559
Huang J, Rauscher S, Nawrocki G et al (2017) CHARMM36m: an improved force field for folded and intrinsically disordered proteins. Nat Methods 14:71–73. https://doi.org/10.1038/nmeth.4067
Humphrey W, Dalke A, Schulten K (1996) VMD: visual molecular dynamics. J Mol Graph Model 14:33–38. https://doi.org/10.1016/0263-7855(96)00018-5
Pisani P, Caporuscio F, Carlino L et al (2016) Molecular dynamics simulations and classical multidimensional scaling unveil new metastable states in the conformational landscape of CDK2. PLoS One 11:e0154066. https://doi.org/10.1371/journal.pone.0154066
Comitani F, Gervasio FL (2018) Exploring cryptic pockets formation in targets of pharmaceutical interest with SWISH. J Chem Theory Comput 14:3321–3331. https://doi.org/10.1021/acs.jctc.8b00263
Acknowledgments
This work was supported by UOTT grant Inkubator Innowacyjności 4.0 to A.K.-B.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Gniado, N., Krawczyk-Balska, A., Mehta, P., Miszta, P., Filipek, S. (2023). Protein Homology Modeling for Effective Drug Design. In: Filipek, S. (eds) Homology Modeling. Methods in Molecular Biology, vol 2627. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-2974-1_18
Download citation
DOI: https://doi.org/10.1007/978-1-0716-2974-1_18
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-2973-4
Online ISBN: 978-1-0716-2974-1
eBook Packages: Springer Protocols